• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Aduro Clean Technologies Inc
Aduro Clean Technologies Inc
Waseco Resources Inc
Edit Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Pfizer (NY:PFE)

27.61 +0.07 (+0.25%)
Delayed Quote Updated: 12:02 PM EST, Nov 20, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Pfizer

< Previous 1 2 3 4 5 6 7 8 9
...
42 43 Next >
News headline image
Pfizer Enters into Exclusive Licensing Agreement with Starna Therapeutics for Autoimmune Diseases
November 18, 2026
From Pfizer Inc.
Via Business Wire
News headline image
Pfizer and Blackstone Life Sciences Announce Strategic Funding Agreement for Obesity Program
November 11, 2026
From Pfizer Inc.
Via Business Wire
News headline image
Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference
November 10, 2026
From Pfizer Inc.
Via Business Wire
News headline image
6th Annual Sickle Cell Caregiver Summit Brings Global Voices Together to Strengthen Families, Advocacy, and Caregiver Wellness
November 08, 2026
November 8, 2026 -- November 13–15 Virtual Event Connects Caregivers, Healthcare Professionals, and Advocates Across Borders 
Via 24-7 Press Release
News headline image
Pfizer Reports Strong Third-Quarter 2026 Results And Raises 2026 Guidance
November 03, 2026
From Pfizer Inc.
Via Business Wire
News headline image
Pfizer Appoints Cecile Guegan as Chief Financial Officer
November 03, 2026
From Pfizer Inc.
Via Business Wire
News headline image
Corporate headshot photographer NYC Michael Benabib recently recognized for his work in a one-man show in Tokyo
November 02, 2026
Via AB Newswire
News headline image
Pfizer’s ELREXFIO Outperforms Standard Regimens and Meets Primary Endpoint in Phase 3 Study in Relapsed or Refractory Multiple Myeloma
October 27, 2026
From Pfizer Inc.
Via Business Wire
News headline image
Pfizer’s TALZENNA Plus XTANDI FDA-Approved for an Earlier Metastatic Prostate Cancer Treatment Setting
October 26, 2026
From Pfizer Inc.
Via Business Wire
News headline image
Immuno-Oncology Emerges as a Major Force in the Global Cancer Treatment Market
October 26, 2026
EQNX::TICKER_START (NASDAQ:GTBP),(NASDAQ:MRNA),(NASDAQ:IOVA),(NASDAQ:GMAB),(NYSE:PFE) EQNX::TICKER_END 
Via FinancialNewsMedia
News headline image
Pfizer's 25-Valent Pediatric Pneumococcal Conjugate Vaccine Candidate Shows Robust Phase 2 Data at IDWeek 2026
October 24, 2026
From Pfizer Inc.
Via Business Wire
News headline image
Pfizer Showcases Clinical Advancements Across Infectious Diseases at IDWeek 2026
October 14, 2026
From Pfizer Inc.
Via Business Wire
News headline image
Avident Health and Unite for HER Awarded Quality Improvement Grant from Pfizer and the National Comprehensive Cancer Network® (NCCN®) to Support Metastatic Breast Cancer Patients
October 08, 2026
October 8, 2026 -- Initiative leverages the MyNavigator™ digital care coordination platform to translate NCCN Guidelines® into actionable home-based education, expand access to integrative oncology... 
Via 24-7 Press Release
News headline image
Pfizer’s TUKYSA Regimen Receives FDA Approval as Front-Line Maintenance Treatment for HER2+ Metastatic Breast Cancer
October 07, 2026
From Pfizer Inc.
Via Business Wire
News headline image
Pfizer Declares Fourth-Quarter 2026 Dividend
October 06, 2026
From Pfizer Inc.
Via Business Wire
News headline image
Pfizer’s LITFULO Significantly Improved Facial and Total Body Repigmentation in Patients with Nonsegmental Vitiligo
October 02, 2026
From Pfizer Inc
Via Business Wire
News headline image
Pfizer's Tilrekimig Shows Significant Skin Clearance in Phase 2 Atopic Dermatitis Study
October 01, 2026
From Pfizer Inc.
Via Business Wire
News headline image
Pfizer Advances Today’s Cancer Care and Tomorrow's Potential Breakthroughs at ESMO
September 28, 2026
From Pfizer Inc.
Via Business Wire
News headline image
Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
September 15, 2026
From Pfizer Inc.
Via Business Wire
News headline image
A $57 Billion Antiviral Market Is Taking Shape As The World Prepares For The Next Viral Threat
September 15, 2026
EQNX::TICKER_START (NYSE:NNVC),(NASDAQ:GILD),(NASDAQ:MRNA),(NYSE:PFE),(NASDAQ:BNTX) EQNX::TICKER_END 
Via FinancialNewsMedia
News headline image
A $57 Billion Antiviral Market Is Taking Shape As The World Prepares For The Next Viral Threat
September 15, 2026
A Growing Global Threat From Emerging Viruses Is Fueling Urgent Demand For New Treatments And Creating A Potentially Massive Market For Innovative Antiviral Developers 
From MarketNewsUpdates.com
Via GlobeNewswire
News headline image
2025 R&D Spending And Intensity Benchmarks
September 09, 2026
Via PRLog
Topics Supply Chain
News headline image
Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
September 08, 2026
From Pfizer Inc.
Via Business Wire
News headline image
Pfizer and BioNTech Receive U.S. FDA Approval for XFG-adapted COVID-19 Vaccine
August 27, 2026
From Pfizer Inc.
Via Business Wire
News headline image
Pfizer and Valneva’s Lyme Disease Vaccine Candidate Marketing Authorization Application Validated by European Medicines Agency
August 14, 2026
From Pfizer Inc.
Via Business Wire
News headline image
Pfizer Reports Second-Quarter Results And Raises Midpoint of 2026 Revenue Guidance
August 04, 2026
From Pfizer Inc.
Via Business Wire
News headline image
Pfizer Announces Positive Topline Phase 3 Results for LITFULO in Patients with Nonsegmental Vitiligo
July 30, 2026
From Pfizer Inc.
Via Business Wire
News headline image
What Health Experts Want You to Know About Pneumococcal Pneumonia
July 30, 2026
Via StatePoint Media
News headline image
European Commission Authorizes Pfizer and BioNTech XFG-adapted COVID-19 Vaccine in the European Union
July 29, 2026
From Pfizer Inc.
Via Business Wire
News headline image
FDA Grants Priority Review for Pfizer’s TALZENNA Plus XTANDI for the Treatment of Metastatic Prostate Cancer
July 22, 2026
From Pfizer Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9
...
42 43 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap